Arixtra (onelink)
Arixtra (Onelink) Recall Summary Arixtra (Onelink) 7.5 mg/0.6mL injection solution is being recalled in New Zealand. This is a Class I recall, which is the most serious classification. The recall was initiated as a product alert and affects healthcare professionals in New Zealand.
- Recalling firm
- Onelink
- Product
- Arixtra (Onelink). [Medicine]. Form: Solution for injection 7.5 mg/0.6mL
- Reason
- Viatris(MAH) has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.
- Classification
- Class I
- Category
- drug recall
- Country
- New Zealand
- Agency
- MEDSAFE
- Recall date
- 2026-03-18
- Status
- Ongoing
- Distribution
- New Zealand - Healthcare Professional
Official recall notice from MEDSAFE
Recall details on Nibble Recalls: https://trynibble.app/recalls/47fbc011-4409-4df7-a410-6f3e8ecb5f3f